RO7020322
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO7020322, covering 2017-05-25 to 2017-05-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients [Phase 1]